The Role of the Fujinon Intelligent Chromo Endoscopy (FICE™) in Barrett's Esophagus

Completed

• Conditions: Barrett's Esophagus

• Registration Number: NCT01084629
• Lead Sponsor: Mayo Clinic

Brief Summary

The purpose of this study to assess post ablation, if there are areas of Barrett's mucosa post ablation and to assess the ability of the Fujinon FICE system to detect this, as compared to white light endoscopy. A subgroup will also be compared with laser confocal microscopy

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-03-09
• Study First Submitted QC: 2010-03-09
• Study First Posted: 2010-03-10
• Study Start: 2010-11
• Primary Completion: 2016-11-04
• Study Completion: 2016-11-04
• Status Verified: 2021-12
• Last Update Submitted: 2021-12-13
• Last Update Posted: 2021-12-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Visible Barrett's esophagus
• Scheduled for Surveillance Endoscopy
• Able to undergo endoscopy

Read More

Exclusion Criteria

• Unable to undergo endoscopy
• Unable to stop blood thinning medications

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
detection of dysplasic areas	during surveillance endoscopy	Areas of residual mucosa will be scored for being present, absent or suspicious. The ability of both FICE and white light endoscopy to find areas will be graded on the number of areas found, and the size of the areas estimated at the time of endoscopy

Trial Locations

Locations (1)

Mayo Clinic Rochester; 🇺🇸 Rochester, Minnesota, United States